Leo Smit, Hy2Care – CartRevive® | LSI Asia '25

Hy2Care is a clinical phase company pursuing a breakthrough therapy with its CartRevive® hydrogel implant. The company’s vision is to support patients in the fight against osteoarthritis. Its lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.